Scientists present landmark women’s health trials in PMS and PMDD

Dr Rachael Sumner discusses landmark women’s health trials. Microdosing MB22001 for negative mood symptom alleviation in PMS and PMDD.

Positive Phase 2a results reported in Depression trial.

Previous
Previous

Update on Phase 2B Clinical Trials

Next
Next

Sleep Paper published in Prestigious Scientific Journal